Connection
John Kinsella to Phosphodiesterase Inhibitors
This is a "connection" page, showing publications John Kinsella has written about Phosphodiesterase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.374 |
|
|
|
-
Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to nitric oxide. Lancet. 1995 Sep 02; 346(8975):647-8.
Score: 0.120
-
Steinhorn RH, Kinsella JP, Abman SH. Beyond pulmonary hypertension: sildenafil for chronic lung disease of prematurity. Am J Respir Cell Mol Biol. 2013 Feb; 48(2):iii-v.
Score: 0.100
-
Steinhorn RH, Kinsella JP, Pierce C, Butrous G, Dilleen M, Oakes M, Wessel DL. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr. 2009 Dec; 155(6):841-847.e1.
Score: 0.081
-
Ziegler JW, Ivy DD, Wiggins JW, Kinsella JP, Clarke WR, Abman SH. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med. 1998 Nov; 158(5 Pt 1):1388-95.
Score: 0.037
-
Ivy DD, Kinsella JP, Ziegler JW, Abman SH. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg. 1998 Apr; 115(4):875-82.
Score: 0.036